"instanceType","text","name","uuid:ID","description","label","id","identifier"
"EligibilityCriterion","Subjects shall be between [min_age] and [max_age]","Age Criteria","2da13aa4-b3da-4bdf-8836-30785b58f889","The study age criterion","","EligibilityCriterion_1","1"
"EligibilityCriterion","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","Pop Criteria","a06186d2-21fe-49c3-94bb-cb0a9626d940","The study population criterion","","EligibilityCriterion_2","2"
"EligibilityCriterion","[Activity1] score of 10 to 23","Diag Criteria","8108bc20-4746-4c38-921a-f36c9bb51637","The study diagnosis criterion","","EligibilityCriterion_3","3"
"EligibilityCriterion","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","Previous Criteria","3f7bb05f-aa83-475e-b444-460b08c549ac","The previous xanomeline TTS criterion","","EligibilityCriterion_4","9"
